NCT03684811 2023-11-18
A Study of FT-2102 in Patients With Advanced Solid Tumors and Gliomas With an IDH1 Mutation
Novo Nordisk A/S
Phase 1/2 Completed
Novo Nordisk A/S
Case Comprehensive Cancer Center
Alliance for Clinical Trials in Oncology
Barbara Ann Karmanos Cancer Institute